🔎 Trials Near Me

Početna › Intersticijske bolesti pluća › Texas › Houston

Kliničke studije za Intersticijske bolesti pluća u gradu Houston, TX

12 studija za Intersticijske bolesti pluća traži sudionike na lokacijama u gradu Houston i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.

Službeni tekst studije (engleski)

Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

U tijeku regrutacijaFaza 3
  • Baylor College of Medicine, Houston
Od 40 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07201922

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

U tijeku regrutacijaFaza 3
  • GSK Investigational Site, Houston
Od 18 godina i više · Oba spola · Ažurirano 8. ruj 2026. · NCT06572384

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

U tijeku regrutacijaFaza 2
  • Baylor College of Medicine, Houston
Od 40 godina i više · Oba spola · Ažurirano 4. ruj 2026. · NCT06968845

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

U tijeku regrutacija
  • Baylor College of Medicine, Houston
  • Houston Methodist Hospital, Houston
Od 18 godina i više · Oba spola · Ažurirano 2. ruj 2026. · NCT06911632

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

U tijeku regrutacijaFaza 2
  • Clinical Research Site, Houston
Od 18 do 85 godina · Oba spola · Ažurirano 2. ruj 2026. · NCT07333183

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

U tijeku regrutacijaOpažajna studija
  • Houston Methodist, Houston
  • University of Texas Health Science Center at Houston, Houston
Od 18 godina i više · Oba spola · Ažurirano 26. kol 2026. · NCT06388421

Platform Clinical Study for Conquering Scleroderma

U tijeku regrutacijaFaza 2
  • University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics, Houston
Od 18 godina i više · Oba spola · Ažurirano 18. kol 2026. · NCT06195072

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

U tijeku regrutacijaOpažajna studija
  • Baylor College of Medicine, Houston
  • Houston Methodist Lung Center, Houston
  • The University of Texas Health Science Center At Houston, Houston
Od 21 godina i više · Oba spola · Ažurirano 12. kol 2026. · NCT01915511

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

U tijeku regrutacijaFaza 2
  • Houston Methodist Hospital, Houston
Od 18 do 80 godina · Oba spola · Ažurirano 10. kol 2026. · NCT07175038

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

U tijeku regrutacijaFaza 3
  • Houston Methodist Outpatient Center, Houston
  • The University of Texas Health Science Center at Houston, McGovern Medical School, Houston
Od 18 godina i više · Oba spola · Ažurirano 13. srp 2026. · NCT05943535

TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients

U tijeku regrutacijaOpažajna studija
  • Baylor College of Medicine/Texas Children'S Hospital, Houston
Do 24 godina · Oba spola · Ažurirano 22. lip 2026. · NCT04098445

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

U tijeku regrutacijaFaza 2
  • aTyr Investigative Site, Houston
Od 18 godina i više · Oba spola · Ažurirano 7. svi 2025. · NCT05892614

Studije za Intersticijske bolesti pluća u drugim gradovima

Ostale studije u gradu Houston

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.